Shield Therapeutics PLC ORD 1.5P/ GB00BYV81293 /
2024-04-26 1:25:39 PM | Chg. +0.0050 | Volume | Bid2024-04-26 | Ask2024-04-26 | High | Low |
---|---|---|---|---|---|---|
1.2300GBX | +0.41% | 3.08 mill. Turnover(GBP): 37,800.0096 |
1.1500Bid Size: 30,000 | 1.2500Ask Size: 30,000 | 1.2500 | 1.2025 |
GlobeNewswire
2:00 PM
PRISM MarketView Features DRYWORLD Brands, A Global High-Performance Athleticwear Brand
GlobeNewswire
2:00 PM
Fobi AI Signs Two-Year Sponsorship Agreement With Canadian Equestrian Rider Kassidy Keith
GlobeNewswire
2:00 PM
Monster Beverage to Report Financial Results for 2024 First Quarter on May 2, 2024
GlobeNewswire
2:00 PM
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388...
GlobeNewswire
2:00 PM
First Hawaiian, Inc. Reports First Quarter 2024 Financial Results and Declares Dividend
GlobeNewswire
2:00 PM
Pan American Energy Announces Final Drill Results from 2023/2024 Program at the Big Mack Lithium Pro...
GlobeNewswire
2:00 PM
Star Group, L.P. to Host Fiscal 2024 Second Quarter Webcast and Conference Call May 2, 2024
GlobeNewswire
2:00 PM
Smart for Life Announces Availability of a White Paper on the Nutraceuticals Industry
GlobeNewswire
2:00 PM
Verizon to award $25K crisis-response grant to Maryland Tough Baltimore Strong Key Bridge Fund
GlobeNewswire
2:00 PM
SOND INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sonder Holdings Inc. Investors...
GlobeNewswire
1:57 PM
From Switzerland to the World: Vtrading Launches Global Multilingual Artificial Intelligence Quantit...